Dechra Pharmaceuticals PLC
LSE:DPH
Dechra Pharmaceuticals PLC
Tax Provision
Dechra Pharmaceuticals PLC
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Tax Provision
£8.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Tax Provision
-£754m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
AstraZeneca PLC
LSE:AZN
|
Tax Provision
-$1.1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
-7%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Tax Provision
-$474k
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Tax Provision
-$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Tax Provision
-$89m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-1%
|
See Also
What is Dechra Pharmaceuticals PLC's Tax Provision?
Tax Provision
8.2m
GBP
Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Tax Provision amounts to 8.2m GBP.